Article Correctness Is Author's Responsibility: Drug-delivery technology leads to sustained HIV antibody production in NIH study

(NIH/National Institute of Allergy and Infectious Diseases) A new approach to direct the body to make a specific antibody against HIV led to sustained production of that antibody for more than a year among participants in an NIH clinical trial. This drug-delivery technology uses a harmless virus to deliver an antibody gene into human cells, enabling the body to generate the antibody over extended time. With development, such a strategy could be applied to prevent and treat a variety of infectious diseases.